Showing results (631-640 of 1,787) with videos related to

Sort By:
Pageof 179
Hepatology Communications|April 8, 2020
Immune Checkpoint Axes Are Dysregulated in Patients With Alcoholic HepatitisWei Li, Ying Xia, Jing Yang, et al.
Hepatology Communications|September 12, 2021
Fibrosis-4 Predicts the Need for Mechanical Ventilation in a National Multiethnic Cohort of Corona Virus Disease 2019Richard K Sterling, Dongho Shin, Yongyun Shin, et al.
Hepatology Communications|September 12, 2021
The Matrisome Genes From Hepatitis B-Related Hepatocellular Carcinoma UnveiledWei Chen, Romain Desert, Xiaodong Ge, et al.
Hepatology Communications|September 12, 2021
Obeticholic Acid Decreases Intestinal Content of Enterococcus in Rats With Cirrhosis and AscitesKathleen Yan, Adelina Hung, Caitlin Parmer, et al.
Hepatology Communications|June 9, 2022
A prospective investigation of serum bile acids with risk of liver cancer, fatal liver disease, and biliary tract cancerZeinab Farhat, Neal D Freedman, Joshua N Sampson, et al.
Hepatology Communications|January 12, 2023
Early treatment with terlipressin in patients with hepatorenal syndrome yields improved clinical outcomes in North American studiesMichael P Curry, Hugo E Vargas, Alex S Befeler, et al.
Hepatology Communications|January 12, 2023
Psychosocial assessment in liver transplantation (LT): an analysis of short-term outcomesLindsay A Matthews, Jessica A Musto, Nimrod Deiss-Yehiely, et al.
Hepatology Communications|January 12, 2023
Thioredoxin reductase 1 regulates hepatic inflammation and macrophage activation during acute cholestatic liver injuryColin T Shearn, Aimee L Anderson, Colin G Miller, et al.
Hepatology Communications|January 12, 2023
Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1Junfeng Wang, Min Du, Lingdu Meng, et al.
Hepatology Communications|January 12, 2023
Cost and value in liver disease guidelines: 2011-2022Elizabeth S Aby, Alyson Kaplan, Nneka N Ufere
Pageof 179